home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

Natural Killer Cell Online Symposium 2023

 
  January 12, 2023  
     
 
Oxford Global, Online Symposium
24/05/2023


From new and exciting case studies to the latest in products and services, our online event will bring together leading industry and academic experts for a day of discussion, knowledge sharing and focused networking sessions.

Theme 1: Design & Development of NK-Based Therapies

  • Increasing the safety and persistence of allogeneic NK therapies 
  • Genetic modification of NK cells to retarget and sustain anti-tumour activity 
  • In vitro approaches to accelerate off-target effect & toxicity research 
  • Leveraging mechanism of action to elicit stronger & safer therapeutic activity 
  • Optimised analytical approaches tailored to NK-based therapies 

Theme 2: Application of NK-Based Therapies

  • Utilising the most effective strategy for solid tumours 
  • Harnessing NK cell memory for leukaemia immunotherapy 
  • Case studies of NK & CAR-NK clinical trials for haematological malignancies 
  • Strategies for combining NK cells with other agents 

 

 
 
Organized by: Oxford Global
Invited Speakers:

Jan Spanholtz - CSO at Glycostem

Marcela Guzman - Director of Research Development at Sentil Biosciences

Aviad Pata - Head of Research at Gamida Cell

Shawn Cogan - Senior CMC Project Manager at Takeda

Bjorn Onfelt - Professor at KTH Royal Institute of Technology

 

 

 
Deadline for Abstracts: 26/04/2023
 
Registration: Book Now - Natural Killer Cell Online Symposium 2023 (oxfordglobal.co.uk)
E-mail: info@oxfordglobal.co.uk
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.